George Miljanich
Oprichter bij SiteOne Therapeutics, Inc.
Profiel
George Miljanich is the founder and Chief Scientific Officer of SiteOne Therapeutics, Inc. which is founded in 2010.
He is currently the Chief Executive Officer at Airmid, Inc. Dr. Miljanich has an undergraduate degree from the University of California, Berkeley and a doctorate from the University of California, Santa Cruz.
Actieve functies van George Miljanich
| Bedrijven | Functie | Begin |
|---|---|---|
SiteOne Therapeutics, Inc.
 SiteOne Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology SiteOne Therapeutics, Inc. develops novel pain therapeutics and diagnostics. Its therapeutic candidates are selective inhibitors of a voltage-gated sodium ion channel. The company was founded by Sandip Biswal, Justin Du Bois, George Miljanich, John Mulcahy and David Yeomans in 2010 and is headquartered in Bozeman, MT. | Oprichter | 01-01-2010 |
Airmid, Inc.
 Airmid, Inc. Pharmaceuticals: MajorHealth Technology Airmid, Inc. manufactures pharmaceutical products. The CEO of the American company is George Miljanich. | Algemeen Directeur | - |
Opleiding van George Miljanich
| University of California, Berkeley | Undergraduate Degree |
| University of California, Santa Cruz | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 2 |
|---|---|
SiteOne Therapeutics, Inc.
SiteOne Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology SiteOne Therapeutics, Inc. develops novel pain therapeutics and diagnostics. Its therapeutic candidates are selective inhibitors of a voltage-gated sodium ion channel. The company was founded by Sandip Biswal, Justin Du Bois, George Miljanich, John Mulcahy and David Yeomans in 2010 and is headquartered in Bozeman, MT. | Health Technology |
Airmid, Inc.
Airmid, Inc. Pharmaceuticals: MajorHealth Technology Airmid, Inc. manufactures pharmaceutical products. The CEO of the American company is George Miljanich. | Health Technology |
